| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 1373373 | Bioorganic & Medicinal Chemistry Letters | 2010 | 6 Pages |
Abstract
Antagonists of the corticotropin-releasing factor (CRF) neuropeptide may prove effective in treating stress and anxiety related disorders. In an effort to identify antagonists with improved physico-chemical properties a new series of CRF1 antagonists were designed to substitute the propyl groups at the C7 position of the pyrazolo[1,5-a]pyrimidine core of 1 with heterocycles. Compound (S)-8d was identified as a high affinity ligand with a pKi value of 8.2 and a functional CRF1 antagonist with pIC50 value of 7.0 in the in vitro CRF ACTH production assay.
Graphical abstractFigure optionsDownload full-size imageDownload as PowerPoint slide
Related Topics
Physical Sciences and Engineering
Chemistry
Organic Chemistry
Authors
John E. Tellew, Marion Lanier, Manisha Moorjani, Emily Lin, Zhiyong Luo, Deborah H. Slee, Xiaohu Zhang, Sam R.J. Hoare, Dimitri E. Grigoriadis, Yves St. Denis, Romano Di Fabio, Enza Di Modugno, John Saunders, John P. Williams,